Global Oncolytic Virus Drug Treatment Supply, Demand and Key Producers, 2024-2030

Description

The global Oncolytic Virus Drug Treatment market size is expected to reach $ 28 million by 2030, rising at a market growth of 23.8% CAGR during the forecast period (2024-2030).

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report studies the global Oncolytic Virus Drug Treatment demand, key companies, and key regions.

This report is a detailed and comprehensive analysis of the world market for Oncolytic Virus Drug Treatment, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2023 as the base year. This report explores demand trends and competition, as well as details the characteristics of Oncolytic Virus Drug Treatment that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global Oncolytic Virus Drug Treatment total market, 2019-2030, (USD Million)
Global Oncolytic Virus Drug Treatment total market by region & country, CAGR, 2019-2030, (USD Million)
U.S. VS China: Oncolytic Virus Drug Treatment total market, key domestic companies and share, (USD Million)
Global Oncolytic Virus Drug Treatment revenue by player and market share 2019-2024, (USD Million)
Global Oncolytic Virus Drug Treatment total market by Type, CAGR, 2019-2030, (USD Million)
Global Oncolytic Virus Drug Treatment total market by Application, CAGR, 2019-2030, (USD Million).

This reports profiles major players in the global Oncolytic Virus Drug Treatment market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Amgen, Oncolytics Biotech, Viralytics, Transgene SA, Oncolys BioPharma, Targovax, PsiOxus Therapeutics, SillaJen Biotherapeutics and Sorrento Therapeutics, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Oncolytic Virus Drug Treatment market.

Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2019-2030 by year with 2023 as the base year, 2024 as the estimate year, and 2025-2030 as the forecast year.

Global Oncolytic Virus Drug Treatment Market, By Region:
    United States
    China
    Europe
    Japan
    South Korea
    ASEAN
    India
    Rest of World

Global Oncolytic Virus Drug Treatment Market, Segmentation by Type
    Phase 1
    Phase 2
    Others

Global Oncolytic Virus Drug Treatment Market, Segmentation by Application
    Melanoma
    Prostate Cancer
    Breast Cancer
    Ovarian Cancer
    Others

Companies Profiled:
    Amgen
    Oncolytics Biotech
    Viralytics
    Transgene SA
    Oncolys BioPharma
    Targovax
    PsiOxus Therapeutics
    SillaJen Biotherapeutics
    Sorrento Therapeutics
    Lokon Pharma
    Genelux Corporation
    Vyriad
    TILT Biotherapeutics
    Cold Genesys

Key Questions Answered
1. How big is the global Oncolytic Virus Drug Treatment market?
2. What is the demand of the global Oncolytic Virus Drug Treatment market?
3. What is the year over year growth of the global Oncolytic Virus Drug Treatment market?
4. What is the total value of the global Oncolytic Virus Drug Treatment market?
5. Who are the major players in the global Oncolytic Virus Drug Treatment market?

Table of Contents

1 Supply Summary
    1.1 Oncolytic Virus Drug Treatment Introduction
    1.2 World Oncolytic Virus Drug Treatment Market Size & Forecast (2019 & 2023 & 2030)
    1.3 World Oncolytic Virus Drug Treatment Total Market by Region (by Headquarter Location)
        1.3.1 World Oncolytic Virus Drug Treatment Market Size by Region (2019-2030), (by Headquarter Location)
        1.3.2 United States Oncolytic Virus Drug Treatment Market Size (2019-2030)
        1.3.3 China Oncolytic Virus Drug Treatment Market Size (2019-2030)
        1.3.4 Europe Oncolytic Virus Drug Treatment Market Size (2019-2030)
        1.3.5 Japan Oncolytic Virus Drug Treatment Market Size (2019-2030)
        1.3.6 South Korea Oncolytic Virus Drug Treatment Market Size (2019-2030)
        1.3.7 ASEAN Oncolytic Virus Drug Treatment Market Size (2019-2030)
        1.3.8 India Oncolytic Virus Drug Treatment Market Size (2019-2030)
    1.4 Market Drivers, Restraints and Trends
        1.4.1 Oncolytic Virus Drug Treatment Market Drivers
        1.4.2 Factors Affecting Demand
        1.4.3 Oncolytic Virus Drug Treatment Major Market Trends

2 Demand Summary
    2.1 World Oncolytic Virus Drug Treatment Consumption Value (2019-2030)
    2.2 World Oncolytic Virus Drug Treatment Consumption Value by Region
        2.2.1 World Oncolytic Virus Drug Treatment Consumption Value by Region (2019-2024)
        2.2.2 World Oncolytic Virus Drug Treatment Consumption Value Forecast by Region (2025-2030)
    2.3 United States Oncolytic Virus Drug Treatment Consumption Value (2019-2030)
    2.4 China Oncolytic Virus Drug Treatment Consumption Value (2019-2030)
    2.5 Europe Oncolytic Virus Drug Treatment Consumption Value (2019-2030)
    2.6 Japan Oncolytic Virus Drug Treatment Consumption Value (2019-2030)
    2.7 South Korea Oncolytic Virus Drug Treatment Consumption Value (2019-2030)
    2.8 ASEAN Oncolytic Virus Drug Treatment Consumption Value (2019-2030)
    2.9 India Oncolytic Virus Drug Treatment Consumption Value (2019-2030)

3 World Oncolytic Virus Drug Treatment Companies Competitive Analysis
    3.1 World Oncolytic Virus Drug Treatment Revenue by Player (2019-2024)
    3.2 Industry Rank and Concentration Rate (CR)
        3.2.1 Global Oncolytic Virus Drug Treatment Industry Rank of Major Players
        3.2.2 Global Concentration Ratios (CR4) for Oncolytic Virus Drug Treatment in 2023
        3.2.3 Global Concentration Ratios (CR8) for Oncolytic Virus Drug Treatment in 2023
    3.3 Oncolytic Virus Drug Treatment Company Evaluation Quadrant
    3.4 Oncolytic Virus Drug Treatment Market: Overall Company Footprint Analysis
        3.4.1 Oncolytic Virus Drug Treatment Market: Region Footprint
        3.4.2 Oncolytic Virus Drug Treatment Market: Company Product Type Footprint
        3.4.3 Oncolytic Virus Drug Treatment Market: Company Product Application Footprint
    3.5 Competitive Environment
        3.5.1 Historical Structure of the Industry
        3.5.2 Barriers of Market Entry
        3.5.3 Factors of Competition
    3.6 Mergers, Acquisitions Activity

4 United States VS China VS Rest of the World (by Headquarter Location)
    4.1 United States VS China: Oncolytic Virus Drug Treatment Revenue Comparison (by Headquarter Location)
        4.1.1 United States VS China: Oncolytic Virus Drug Treatment Market Size Comparison (2019 & 2023 & 2030) (by Headquarter Location)
        4.1.2 United States VS China: Oncolytic Virus Drug Treatment Revenue Market Share Comparison (2019 & 2023 & 2030)
    4.2 United States Based Companies VS China Based Companies: Oncolytic Virus Drug Treatment Consumption Value Comparison
        4.2.1 United States VS China: Oncolytic Virus Drug Treatment Consumption Value Comparison (2019 & 2023 & 2030)
        4.2.2 United States VS China: Oncolytic Virus Drug Treatment Consumption Value Market Share Comparison (2019 & 2023 & 2030)
    4.3 United States Based Oncolytic Virus Drug Treatment Companies and Market Share, 2019-2024
        4.3.1 United States Based Oncolytic Virus Drug Treatment Companies, Headquarters (States, Country)
        4.3.2 United States Based Companies Oncolytic Virus Drug Treatment Revenue, (2019-2024)
    4.4 China Based Companies Oncolytic Virus Drug Treatment Revenue and Market Share, 2019-2024
        4.4.1 China Based Oncolytic Virus Drug Treatment Companies, Company Headquarters (Province, Country)
        4.4.2 China Based Companies Oncolytic Virus Drug Treatment Revenue, (2019-2024)
    4.5 Rest of World Based Oncolytic Virus Drug Treatment Companies and Market Share, 2019-2024
        4.5.1 Rest of World Based Oncolytic Virus Drug Treatment Companies, Headquarters (States, Country)
        4.5.2 Rest of World Based Companies Oncolytic Virus Drug Treatment Revenue, (2019-2024)

5 Market Analysis by Type
    5.1 World Oncolytic Virus Drug Treatment Market Size Overview by Type: 2019 VS 2023 VS 2030
    5.2 Segment Introduction by Type
        5.2.1 Phase 1
        5.2.2 Phase 2
        5.2.3 Others
    5.3 Market Segment by Type
        5.3.1 World Oncolytic Virus Drug Treatment Market Size by Type (2019-2024)
        5.3.2 World Oncolytic Virus Drug Treatment Market Size by Type (2025-2030)
        5.3.3 World Oncolytic Virus Drug Treatment Market Size Market Share by Type (2019-2030)

6 Market Analysis by Application
    6.1 World Oncolytic Virus Drug Treatment Market Size Overview by Application: 2019 VS 2023 VS 2030
    6.2 Segment Introduction by Application
        6.2.1 Melanoma
        6.2.2 Prostate Cancer
        6.2.3 Breast Cancer
        6.2.4 Ovarian Cancer
        6.2.5 Ovarian Cancer
    6.3 Market Segment by Application
        6.3.1 World Oncolytic Virus Drug Treatment Market Size by Application (2019-2024)
        6.3.2 World Oncolytic Virus Drug Treatment Market Size by Application (2025-2030)
        6.3.3 World Oncolytic Virus Drug Treatment Market Size by Application (2019-2030)

7 Company Profiles
    7.1 Amgen
        7.1.1 Amgen Details
        7.1.2 Amgen Major Business
        7.1.3 Amgen Oncolytic Virus Drug Treatment Product and Services
        7.1.4 Amgen Oncolytic Virus Drug Treatment Revenue, Gross Margin and Market Share (2019-2024)
        7.1.5 Amgen Recent Developments/Updates
        7.1.6 Amgen Competitive Strengths & Weaknesses
    7.2 Oncolytics Biotech
        7.2.1 Oncolytics Biotech Details
        7.2.2 Oncolytics Biotech Major Business
        7.2.3 Oncolytics Biotech Oncolytic Virus Drug Treatment Product and Services
        7.2.4 Oncolytics Biotech Oncolytic Virus Drug Treatment Revenue, Gross Margin and Market Share (2019-2024)
        7.2.5 Oncolytics Biotech Recent Developments/Updates
        7.2.6 Oncolytics Biotech Competitive Strengths & Weaknesses
    7.3 Viralytics
        7.3.1 Viralytics Details
        7.3.2 Viralytics Major Business
        7.3.3 Viralytics Oncolytic Virus Drug Treatment Product and Services
        7.3.4 Viralytics Oncolytic Virus Drug Treatment Revenue, Gross Margin and Market Share (2019-2024)
        7.3.5 Viralytics Recent Developments/Updates
        7.3.6 Viralytics Competitive Strengths & Weaknesses
    7.4 Transgene SA
        7.4.1 Transgene SA Details
        7.4.2 Transgene SA Major Business
        7.4.3 Transgene SA Oncolytic Virus Drug Treatment Product and Services
        7.4.4 Transgene SA Oncolytic Virus Drug Treatment Revenue, Gross Margin and Market Share (2019-2024)
        7.4.5 Transgene SA Recent Developments/Updates
        7.4.6 Transgene SA Competitive Strengths & Weaknesses
    7.5 Oncolys BioPharma
        7.5.1 Oncolys BioPharma Details
        7.5.2 Oncolys BioPharma Major Business
        7.5.3 Oncolys BioPharma Oncolytic Virus Drug Treatment Product and Services
        7.5.4 Oncolys BioPharma Oncolytic Virus Drug Treatment Revenue, Gross Margin and Market Share (2019-2024)
        7.5.5 Oncolys BioPharma Recent Developments/Updates
        7.5.6 Oncolys BioPharma Competitive Strengths & Weaknesses
    7.6 Targovax
        7.6.1 Targovax Details
        7.6.2 Targovax Major Business
        7.6.3 Targovax Oncolytic Virus Drug Treatment Product and Services
        7.6.4 Targovax Oncolytic Virus Drug Treatment Revenue, Gross Margin and Market Share (2019-2024)
        7.6.5 Targovax Recent Developments/Updates
        7.6.6 Targovax Competitive Strengths & Weaknesses
    7.7 PsiOxus Therapeutics
        7.7.1 PsiOxus Therapeutics Details
        7.7.2 PsiOxus Therapeutics Major Business
        7.7.3 PsiOxus Therapeutics Oncolytic Virus Drug Treatment Product and Services
        7.7.4 PsiOxus Therapeutics Oncolytic Virus Drug Treatment Revenue, Gross Margin and Market Share (2019-2024)
        7.7.5 PsiOxus Therapeutics Recent Developments/Updates
        7.7.6 PsiOxus Therapeutics Competitive Strengths & Weaknesses
    7.8 SillaJen Biotherapeutics
        7.8.1 SillaJen Biotherapeutics Details
        7.8.2 SillaJen Biotherapeutics Major Business
        7.8.3 SillaJen Biotherapeutics Oncolytic Virus Drug Treatment Product and Services
        7.8.4 SillaJen Biotherapeutics Oncolytic Virus Drug Treatment Revenue, Gross Margin and Market Share (2019-2024)
        7.8.5 SillaJen Biotherapeutics Recent Developments/Updates
        7.8.6 SillaJen Biotherapeutics Competitive Strengths & Weaknesses
    7.9 Sorrento Therapeutics
        7.9.1 Sorrento Therapeutics Details
        7.9.2 Sorrento Therapeutics Major Business
        7.9.3 Sorrento Therapeutics Oncolytic Virus Drug Treatment Product and Services
        7.9.4 Sorrento Therapeutics Oncolytic Virus Drug Treatment Revenue, Gross Margin and Market Share (2019-2024)
        7.9.5 Sorrento Therapeutics Recent Developments/Updates
        7.9.6 Sorrento Therapeutics Competitive Strengths & Weaknesses
    7.10 Lokon Pharma
        7.10.1 Lokon Pharma Details
        7.10.2 Lokon Pharma Major Business
        7.10.3 Lokon Pharma Oncolytic Virus Drug Treatment Product and Services
        7.10.4 Lokon Pharma Oncolytic Virus Drug Treatment Revenue, Gross Margin and Market Share (2019-2024)
        7.10.5 Lokon Pharma Recent Developments/Updates
        7.10.6 Lokon Pharma Competitive Strengths & Weaknesses
    7.11 Genelux Corporation
        7.11.1 Genelux Corporation Details
        7.11.2 Genelux Corporation Major Business
        7.11.3 Genelux Corporation Oncolytic Virus Drug Treatment Product and Services
        7.11.4 Genelux Corporation Oncolytic Virus Drug Treatment Revenue, Gross Margin and Market Share (2019-2024)
        7.11.5 Genelux Corporation Recent Developments/Updates
        7.11.6 Genelux Corporation Competitive Strengths & Weaknesses
    7.12 Vyriad
        7.12.1 Vyriad Details
        7.12.2 Vyriad Major Business
        7.12.3 Vyriad Oncolytic Virus Drug Treatment Product and Services
        7.12.4 Vyriad Oncolytic Virus Drug Treatment Revenue, Gross Margin and Market Share (2019-2024)
        7.12.5 Vyriad Recent Developments/Updates
        7.12.6 Vyriad Competitive Strengths & Weaknesses
    7.13 TILT Biotherapeutics
        7.13.1 TILT Biotherapeutics Details
        7.13.2 TILT Biotherapeutics Major Business
        7.13.3 TILT Biotherapeutics Oncolytic Virus Drug Treatment Product and Services
        7.13.4 TILT Biotherapeutics Oncolytic Virus Drug Treatment Revenue, Gross Margin and Market Share (2019-2024)
        7.13.5 TILT Biotherapeutics Recent Developments/Updates
        7.13.6 TILT Biotherapeutics Competitive Strengths & Weaknesses
    7.14 Cold Genesys
        7.14.1 Cold Genesys Details
        7.14.2 Cold Genesys Major Business
        7.14.3 Cold Genesys Oncolytic Virus Drug Treatment Product and Services
        7.14.4 Cold Genesys Oncolytic Virus Drug Treatment Revenue, Gross Margin and Market Share (2019-2024)
        7.14.5 Cold Genesys Recent Developments/Updates
        7.14.6 Cold Genesys Competitive Strengths & Weaknesses

8 Industry Chain Analysis
    8.1 Oncolytic Virus Drug Treatment Industry Chain
    8.2 Oncolytic Virus Drug Treatment Upstream Analysis
    8.3 Oncolytic Virus Drug Treatment Midstream Analysis
    8.4 Oncolytic Virus Drug Treatment Downstream Analysis

9 Research Findings and Conclusion

10 Appendix
    10.1 Methodology
    10.2 Research Process and Data Source
    10.3 Disclaimer

Table of Figures

List of Tables
    Table 1. World Oncolytic Virus Drug Treatment Revenue by Region (2019, 2023 and 2030) & (USD Million), (by Headquarter Location)
    Table 2. World Oncolytic Virus Drug Treatment Revenue by Region (2019-2024) & (USD Million), (by Headquarter Location)
    Table 3. World Oncolytic Virus Drug Treatment Revenue by Region (2025-2030) & (USD Million), (by Headquarter Location)
    Table 4. World Oncolytic Virus Drug Treatment Revenue Market Share by Region (2019-2024), (by Headquarter Location)
    Table 5. World Oncolytic Virus Drug Treatment Revenue Market Share by Region (2025-2030), (by Headquarter Location)
    Table 6. Major Market Trends
    Table 7. World Oncolytic Virus Drug Treatment Consumption Value Growth Rate Forecast by Region (2019 & 2023 & 2030) & (USD Million)
    Table 8. World Oncolytic Virus Drug Treatment Consumption Value by Region (2019-2024) & (USD Million)
    Table 9. World Oncolytic Virus Drug Treatment Consumption Value Forecast by Region (2025-2030) & (USD Million)
    Table 10. World Oncolytic Virus Drug Treatment Revenue by Player (2019-2024) & (USD Million)
    Table 11. Revenue Market Share of Key Oncolytic Virus Drug Treatment Players in 2023
    Table 12. World Oncolytic Virus Drug Treatment Industry Rank of Major Player, Based on Revenue in 2023
    Table 13. Global Oncolytic Virus Drug Treatment Company Evaluation Quadrant
    Table 14. Head Office of Key Oncolytic Virus Drug Treatment Player
    Table 15. Oncolytic Virus Drug Treatment Market: Company Product Type Footprint
    Table 16. Oncolytic Virus Drug Treatment Market: Company Product Application Footprint
    Table 17. Oncolytic Virus Drug Treatment Mergers & Acquisitions Activity
    Table 18. United States VS China Oncolytic Virus Drug Treatment Market Size Comparison, (2019 & 2023 & 2030) & (USD Million)
    Table 19. United States VS China Oncolytic Virus Drug Treatment Consumption Value Comparison, (2019 & 2023 & 2030) & (USD Million)
    Table 20. United States Based Oncolytic Virus Drug Treatment Companies, Headquarters (States, Country)
    Table 21. United States Based Companies Oncolytic Virus Drug Treatment Revenue, (2019-2024) & (USD Million)
    Table 22. United States Based Companies Oncolytic Virus Drug Treatment Revenue Market Share (2019-2024)
    Table 23. China Based Oncolytic Virus Drug Treatment Companies, Headquarters (Province, Country)
    Table 24. China Based Companies Oncolytic Virus Drug Treatment Revenue, (2019-2024) & (USD Million)
    Table 25. China Based Companies Oncolytic Virus Drug Treatment Revenue Market Share (2019-2024)
    Table 26. Rest of World Based Oncolytic Virus Drug Treatment Companies, Headquarters (States, Country)
    Table 27. Rest of World Based Companies Oncolytic Virus Drug Treatment Revenue, (2019-2024) & (USD Million)
    Table 28. Rest of World Based Companies Oncolytic Virus Drug Treatment Revenue Market Share (2019-2024)
    Table 29. World Oncolytic Virus Drug Treatment Market Size by Type, (USD Million), 2019 & 2023 & 2030
    Table 30. World Oncolytic Virus Drug Treatment Market Size by Type (2019-2024) & (USD Million)
    Table 31. World Oncolytic Virus Drug Treatment Market Size by Type (2025-2030) & (USD Million)
    Table 32. World Oncolytic Virus Drug Treatment Market Size by Application, (USD Million), 2019 & 2023 & 2030
    Table 33. World Oncolytic Virus Drug Treatment Market Size by Application (2019-2024) & (USD Million)
    Table 34. World Oncolytic Virus Drug Treatment Market Size by Application (2025-2030) & (USD Million)
    Table 35. Amgen Basic Information, Area Served and Competitors
    Table 36. Amgen Major Business
    Table 37. Amgen Oncolytic Virus Drug Treatment Product and Services
    Table 38. Amgen Oncolytic Virus Drug Treatment Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 39. Amgen Recent Developments/Updates
    Table 40. Amgen Competitive Strengths & Weaknesses
    Table 41. Oncolytics Biotech Basic Information, Area Served and Competitors
    Table 42. Oncolytics Biotech Major Business
    Table 43. Oncolytics Biotech Oncolytic Virus Drug Treatment Product and Services
    Table 44. Oncolytics Biotech Oncolytic Virus Drug Treatment Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 45. Oncolytics Biotech Recent Developments/Updates
    Table 46. Oncolytics Biotech Competitive Strengths & Weaknesses
    Table 47. Viralytics Basic Information, Area Served and Competitors
    Table 48. Viralytics Major Business
    Table 49. Viralytics Oncolytic Virus Drug Treatment Product and Services
    Table 50. Viralytics Oncolytic Virus Drug Treatment Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 51. Viralytics Recent Developments/Updates
    Table 52. Viralytics Competitive Strengths & Weaknesses
    Table 53. Transgene SA Basic Information, Area Served and Competitors
    Table 54. Transgene SA Major Business
    Table 55. Transgene SA Oncolytic Virus Drug Treatment Product and Services
    Table 56. Transgene SA Oncolytic Virus Drug Treatment Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 57. Transgene SA Recent Developments/Updates
    Table 58. Transgene SA Competitive Strengths & Weaknesses
    Table 59. Oncolys BioPharma Basic Information, Area Served and Competitors
    Table 60. Oncolys BioPharma Major Business
    Table 61. Oncolys BioPharma Oncolytic Virus Drug Treatment Product and Services
    Table 62. Oncolys BioPharma Oncolytic Virus Drug Treatment Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 63. Oncolys BioPharma Recent Developments/Updates
    Table 64. Oncolys BioPharma Competitive Strengths & Weaknesses
    Table 65. Targovax Basic Information, Area Served and Competitors
    Table 66. Targovax Major Business
    Table 67. Targovax Oncolytic Virus Drug Treatment Product and Services
    Table 68. Targovax Oncolytic Virus Drug Treatment Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 69. Targovax Recent Developments/Updates
    Table 70. Targovax Competitive Strengths & Weaknesses
    Table 71. PsiOxus Therapeutics Basic Information, Area Served and Competitors
    Table 72. PsiOxus Therapeutics Major Business
    Table 73. PsiOxus Therapeutics Oncolytic Virus Drug Treatment Product and Services
    Table 74. PsiOxus Therapeutics Oncolytic Virus Drug Treatment Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 75. PsiOxus Therapeutics Recent Developments/Updates
    Table 76. PsiOxus Therapeutics Competitive Strengths & Weaknesses
    Table 77. SillaJen Biotherapeutics Basic Information, Area Served and Competitors
    Table 78. SillaJen Biotherapeutics Major Business
    Table 79. SillaJen Biotherapeutics Oncolytic Virus Drug Treatment Product and Services
    Table 80. SillaJen Biotherapeutics Oncolytic Virus Drug Treatment Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 81. SillaJen Biotherapeutics Recent Developments/Updates
    Table 82. SillaJen Biotherapeutics Competitive Strengths & Weaknesses
    Table 83. Sorrento Therapeutics Basic Information, Area Served and Competitors
    Table 84. Sorrento Therapeutics Major Business
    Table 85. Sorrento Therapeutics Oncolytic Virus Drug Treatment Product and Services
    Table 86. Sorrento Therapeutics Oncolytic Virus Drug Treatment Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 87. Sorrento Therapeutics Recent Developments/Updates
    Table 88. Sorrento Therapeutics Competitive Strengths & Weaknesses
    Table 89. Lokon Pharma Basic Information, Area Served and Competitors
    Table 90. Lokon Pharma Major Business
    Table 91. Lokon Pharma Oncolytic Virus Drug Treatment Product and Services
    Table 92. Lokon Pharma Oncolytic Virus Drug Treatment Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 93. Lokon Pharma Recent Developments/Updates
    Table 94. Lokon Pharma Competitive Strengths & Weaknesses
    Table 95. Genelux Corporation Basic Information, Area Served and Competitors
    Table 96. Genelux Corporation Major Business
    Table 97. Genelux Corporation Oncolytic Virus Drug Treatment Product and Services
    Table 98. Genelux Corporation Oncolytic Virus Drug Treatment Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 99. Genelux Corporation Recent Developments/Updates
    Table 100. Genelux Corporation Competitive Strengths & Weaknesses
    Table 101. Vyriad Basic Information, Area Served and Competitors
    Table 102. Vyriad Major Business
    Table 103. Vyriad Oncolytic Virus Drug Treatment Product and Services
    Table 104. Vyriad Oncolytic Virus Drug Treatment Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 105. Vyriad Recent Developments/Updates
    Table 106. Vyriad Competitive Strengths & Weaknesses
    Table 107. TILT Biotherapeutics Basic Information, Area Served and Competitors
    Table 108. TILT Biotherapeutics Major Business
    Table 109. TILT Biotherapeutics Oncolytic Virus Drug Treatment Product and Services
    Table 110. TILT Biotherapeutics Oncolytic Virus Drug Treatment Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 111. TILT Biotherapeutics Recent Developments/Updates
    Table 112. Cold Genesys Basic Information, Area Served and Competitors
    Table 113. Cold Genesys Major Business
    Table 114. Cold Genesys Oncolytic Virus Drug Treatment Product and Services
    Table 115. Cold Genesys Oncolytic Virus Drug Treatment Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
    Table 116. Global Key Players of Oncolytic Virus Drug Treatment Upstream (Raw Materials)
    Table 117. Oncolytic Virus Drug Treatment Typical Customers
List of Figure
    Figure 1. Oncolytic Virus Drug Treatment Picture
    Figure 2. World Oncolytic Virus Drug Treatment Total Market Size: 2019 & 2023 & 2030, (USD Million)
    Figure 3. World Oncolytic Virus Drug Treatment Total Market Size (2019-2030) & (USD Million)
    Figure 4. World Oncolytic Virus Drug Treatment Revenue Market Share by Region (2019, 2023 and 2030) & (USD Million) , (by Headquarter Location)
    Figure 5. World Oncolytic Virus Drug Treatment Revenue Market Share by Region (2019-2030), (by Headquarter Location)
    Figure 6. United States Based Company Oncolytic Virus Drug Treatment Revenue (2019-2030) & (USD Million)
    Figure 7. China Based Company Oncolytic Virus Drug Treatment Revenue (2019-2030) & (USD Million)
    Figure 8. Europe Based Company Oncolytic Virus Drug Treatment Revenue (2019-2030) & (USD Million)
    Figure 9. Japan Based Company Oncolytic Virus Drug Treatment Revenue (2019-2030) & (USD Million)
    Figure 10. South Korea Based Company Oncolytic Virus Drug Treatment Revenue (2019-2030) & (USD Million)
    Figure 11. ASEAN Based Company Oncolytic Virus Drug Treatment Revenue (2019-2030) & (USD Million)
    Figure 12. India Based Company Oncolytic Virus Drug Treatment Revenue (2019-2030) & (USD Million)
    Figure 13. Oncolytic Virus Drug Treatment Market Drivers
    Figure 14. Factors Affecting Demand
    Figure 15. World Oncolytic Virus Drug Treatment Consumption Value (2019-2030) & (USD Million)
    Figure 16. World Oncolytic Virus Drug Treatment Consumption Value Market Share by Region (2019-2030)
    Figure 17. United States Oncolytic Virus Drug Treatment Consumption Value (2019-2030) & (USD Million)
    Figure 18. China Oncolytic Virus Drug Treatment Consumption Value (2019-2030) & (USD Million)
    Figure 19. Europe Oncolytic Virus Drug Treatment Consumption Value (2019-2030) & (USD Million)
    Figure 20. Japan Oncolytic Virus Drug Treatment Consumption Value (2019-2030) & (USD Million)
    Figure 21. South Korea Oncolytic Virus Drug Treatment Consumption Value (2019-2030) & (USD Million)
    Figure 22. ASEAN Oncolytic Virus Drug Treatment Consumption Value (2019-2030) & (USD Million)
    Figure 23. India Oncolytic Virus Drug Treatment Consumption Value (2019-2030) & (USD Million)
    Figure 24. Producer Shipments of Oncolytic Virus Drug Treatment by Player Revenue ($MM) and Market Share (%): 2023
    Figure 25. Global Four-firm Concentration Ratios (CR4) for Oncolytic Virus Drug Treatment Markets in 2023
    Figure 26. Global Four-firm Concentration Ratios (CR8) for Oncolytic Virus Drug Treatment Markets in 2023
    Figure 27. United States VS China: Oncolytic Virus Drug Treatment Revenue Market Share Comparison (2019 & 2023 & 2030)
    Figure 28. United States VS China: Oncolytic Virus Drug Treatment Consumption Value Market Share Comparison (2019 & 2023 & 2030)
    Figure 29. World Oncolytic Virus Drug Treatment Market Size by Type, (USD Million), 2019 & 2023 & 2030
    Figure 30. World Oncolytic Virus Drug Treatment Market Size Market Share by Type in 2023
    Figure 31. Phase 1
    Figure 32. Phase 2
    Figure 33. Others
    Figure 34. World Oncolytic Virus Drug Treatment Market Size Market Share by Type (2019-2030)
    Figure 35. World Oncolytic Virus Drug Treatment Market Size by Application, (USD Million), 2019 & 2023 & 2030
    Figure 36. World Oncolytic Virus Drug Treatment Market Size Market Share by Application in 2023
    Figure 37. Melanoma
    Figure 38. Prostate Cancer
    Figure 39. Breast Cancer
    Figure 40. Ovarian Cancer
    Figure 41. Others
    Figure 42. Oncolytic Virus Drug Treatment Industrial Chain
    Figure 43. Methodology
    Figure 44. Research Process and Data Source

Companies Mentioned

Amgen
Oncolytics Biotech
Viralytics
Transgene SA
Oncolys BioPharma
Targovax
PsiOxus Therapeutics
SillaJen Biotherapeutics
Sorrento Therapeutics
Lokon Pharma
Genelux Corporation
Vyriad
TILT Biotherapeutics
Cold Genesys